v. 117 (2022)

First report of Leishmania RNA virus 1 in Leishmania (Viannia) braziliensis clinical isolates from Rio de Janeiro State - Brazil

Lack of association of the KIR and HLA class I ligands with ZIKV infection in south and southeast of Brazil

Leishmania enriettii visceralises in the trachea, lungs, and spleen of Cavia porcellus

Detection of non-tuberculosus mycobacteria (NTMs) in lung samples using 16S rRNA

Suitability of methods for Plasmodium falciparum cultivation in atmospheric air

Design of a specific peptide against phenolic glycolipid-1 from Mycobacterium leprae and its implications in leprosy bacilli entry

Toxoplasma gondii in the faeces of wild felids from the Atlantic Forest, Brazil

Chagas disease affects the human placental barrier’s turnover dynamics during pregnancy

Prevalence and force of Plasmodium vivax blood-stage infection and associated clinical malaria burden in the Brazilian Amazon

Molecular detection of omicron SARS-CoV-2 variant is achieved by RT-LAMP despite genomic mutations

Binding of the extracellular matrix laminin-1 to Clostridioides difficile strains

CCR6 expression reduces mouse survival upon malarial challenge with Plasmodium berghei NK65 strain

The scientific publication of the Memórias do Instituto Oswaldo Cruz (1909-2020): a history of contribution to the biomedical sciences

Association of CD209 (DC-SIGN) rs735240 SNV with paucibacillary leprosy in the Brazilian population and its functional effects

First report and genome sequencing of SARS-CoV-2 in a cat (Felis catus) in Colombia

Mitochondrial dysfunction on Leishmania (Leishmania) amazonensis induced by ketoconazole: insights into drug mode of action

Homozygotes NAT2*5B slow acetylators are highly associated with hepatotoxicity induced by anti-tuberculosis drugs

Molecular aspects of Chikungunya virus infections in cancer patients

Callitrichine gammaherpesvirus 3 and Human alphaherpesvirus 1 in New World Primate negative for yellow fever virus in Rio de Janeiro, Brazil

Accuracy of rapid point-of-care serological tests for leprosy diagnosis: a systematic review and meta-analysis

Mapping Yellow fever epidemics as a potential indicator of the historical range of Aedes aegypti in the United States

Genomic surveillance: a potential shortcut for effective Chagas disease management

Family Herpesviridae and neuroinfections: current status and research in progress

Article-processing charges as a barrier for science in low-to-medium income regions

Host cholesterol influences the activity of sterol biosynthesis inhibitors in Leishmania amazonensis

Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target

Proteolytic inhibitors as alternative medicines to treat trypanosomatid-caused diseases: experience with calpain inhibitors

Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach*

Translational research in Chagas disease: perspectives in nutritional therapy emerging from selenium supplementation studies as a complementary treatment

Antileishmanial metallodrugs and the elucidation of new drug targets linked to post-translational modifications machinery: pitfalls and progress

Perspectives for a new drug candidate for Chagas disease therapy

Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors

Computational approaches towards the discovery and optimisation of cruzain inhibitors

Past and future of trypanosomatids high-throughput phenotypic screening

Antioxidant defence system as a rational target for Chagas disease and Leishmaniasis chemotherapy

Transforming growth factor-ß as a therapeutic target for the cardiac damage of Chagas disease

Is the mitochondrion a promising drug target in trypanosomatids?

Animal models and SARS-CoV-2-induced pulmonary and neurological injuries

How people affected by Chagas disease have struggled with their negligence: history, associative movement and World Chagas Disease Day

Population movements, borders, and Chagas disease

Chagas disease control-surveillance in the Americas: the multinational initiatives and the practical impossibility of interrupting vector-borne Trypanosoma cruzi transmission

Critical analysis of Chagas disease treatment in different countries

A history of over 40 years of potentially pathogenic free-living amoeba studies in Brazil - a systematic review

Prognosis of chronic Chagas heart disease and other pending clinical challenges

The multidimensional comprehension of Chagas disease. Contributions, approaches, challenges and opportunities from and beyond the Information, Education and Communication field

Chagas disease in the context of the 2030 agenda: global warming and vectors

Parasitological, serological and molecular diagnosis of acute and chronic Chagas disease: from field to laboratory

The translational challenge in Chagas disease drug development

Different profiles and epidemiological scenarios: past, present and future

The history of Chagas disease: reflections on science in action

Inscrever-se em v. 117 (2022)